Captrust Financial Advisors Exact Sciences Corp Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
A detailed history of Captrust Financial Advisors transactions in Exact Sciences Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 22,527 shares of EXAS stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,527
Previous 7,294
208.84%
Holding current value
$1.51 Million
Previous $315,000
280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding EXAS
# of Institutions
660Shares Held
158MCall Options Held
1.43MPut Options Held
2.35M-
Capital World Investors Los Angeles, CA18.2MShares$1.22 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.2 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$808 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$804 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$360 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...